Geron, Inc. will file IND for spinal cord injury as soon as next year. They have two human embryonic stem cell lines that first differentiate into neural progenitors, and then into neurons and oligodendrocytes. Their stem cells line were produced before Bush's ban and have been cleared for use by the FDA. They are stable and free of animal cells and viruses.

Stem Cells, Inc, is engaged in preclincal testing of its patented neural stem cells in a number of animal models for CNS disease including SCI.